SBIO ETF: ALPS Medical Breakthroughs ETF - Price, Holdings & Analysis
ALPS Medical Breakthroughs ETF Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fund characteristics, expense ratio, dividend yield, and performance metrics
Frequently Asked Questions About ALPS Medical Breakthroughs ETF
What is the current price of SBIO?
The latest SBIO price is $63.29. The 52-week range is $35.43–$70.85. SBIO has returned 75.4% over the past 52 weeks.
What is the expense ratio for SBIO?
SBIO's annual expense ratio is 0.50%. This represents the yearly cost of holding the fund, deducted from total returns. Compare with similar Equity ETFs in the ETF Screener.
Does SBIO pay dividends?
ALPS Medical Breakthroughs ETF does not currently pay dividends. Check the ETF Screener for dividend-focused alternatives in the Equity category.
What are the top holdings of SBIO?
SBIO's largest holdings are Crinetics Pharmaceuticals, Inc. (4.7%), Apogee Therapeutics, Inc. (4.5%), Xenon Pharmaceuticals Inc (3.4%) (combined weight: 12.6%). The fund holds 107 total positions. View the complete portfolio breakdown in the Holdings section.
How does SBIO compare to similar ETFs?
Compare SBIO (0.50% expense ratio, $207M AUM) against similar Equity ETFs using the ETF Screener. Filter by expense ratio, dividend yield, and performance to find alternatives.